Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160

Journal of Investigative Dermatology

Volumn 131, Issue 4, 2011, Pages 916-924

  Ortonne, Nicolas ^a   Ram Wolff, Caroline ^a   Giustiniani, Jérme ^b   Marie Cardine, Anne ^b   Bagot, Martine ^b   Mecheri, Salaheddine ^c   Bensussan, Armand ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; GLYCOSYLPHOSPHATIDYLINOSITOL; ISOPROTEIN; PHOSPHOLIPASE D2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIVISION; CELL LINE; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IN VIVO STUDY; MAST CELL; MAST CELL DEGRANULATION; MEMBRANE RECONSTITUTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT;

EID: 79952767497     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.412     Document Type: Article

References (48)

1. Abecassis S, Giustiniani J, Meyer N et al. (2007) Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. J Invest Dermatol 127:1161-6 (Pubitemid 46625147)
2. Agrawal S, Marquet J, Freeman GJ et al. (1999) Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 162:1223-6 (Pubitemid 29306988)
3. Anumanthan A, Bensussan A, Boumsell L et al. (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161:2780-90 (Pubitemid 28425697)
4. Bachelet I, Munitz A, Mankutad D et al. (2006) Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): a novel interface in the allergic process. J Biol Chem 281:27190-6 (Pubitemid 44401748)
5. Barakonyi A, Rabot M, Marie-Cardine A et al. (2004) Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J Immunol 173:5349-54 (Pubitemid 39392117)
6. Bensussan A, Gluckman E, el Marsafy S et al. (1994) BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc Natl Acad Sci USA 91:9136-40
7. Bochner BS (2009) Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy 39:317-24
8. Brain SD, Williams TJ (1988) Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335:73-5
9. Bryce PJ, Miller ML, Miyajima I et al. (2004) Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20:381-92 (Pubitemid 38482117)
10. Butcher S, Arney KL, Cook GP (1998) MAFA-L, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells. Eur J Immunol 28:3755-62 (Pubitemid 28510786)
11. Byrne SN, Limon-Flores AY, Ullrich SE (2008) Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 180:4648-55
12. Cai G, Anumanthan A, Brown JA et al. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9:176-85
13. Choi WS, Kim YM, Combs C et al. (2002) Phospholipases D1 and D2 regulate different phases of exocytosis in mast cells. J Immunol 168:5682-9 (Pubitemid 34556151)
14. Fons P, Chabot S, Cartwright JE et al. (2006) Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108:2608-15
15. Frandji P, Mourad W, Tkaczyk C et al. (1998) IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. Eur J Immunol 28:844-54 (Pubitemid 28116197)
16. Giustiniani J, Bensussan A, Marie-Cardine A (2009) Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 182:63-71
17. Giustiniani J, Marie-Cardine A, Bensussan A (2007) A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol 178:1293-300 (Pubitemid 46154599)
18. Gri G, Piconese S, Frossi B et al. (2008) CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29:771-81
19. Grimbaldeston MA, Metz M, Yu M et al. (2006) Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 18:751-60 (Pubitemid 44642318)
20. Hart PH, Grimbaldeston MA, Swift GJ et al. (1998) Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187:2045-53 (Pubitemid 28285574)
21. Jutel M, Watanabe T, Klunker S et al. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420-5 (Pubitemid 32928596)
22. Katz HR (2007) Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors. Immunol Rev 217:222-30 (Pubitemid 46718155)
23. Kojima T, Obata K, Mukai K et al. (2007) Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner. J Immunol 179:7093-100
24. Le Bouteiller P, Barakonyi A, Giustiniani J et al. (2002) Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 99:16963-8 (Pubitemid 36034081)
25. Lee DM, Friend DS, Gurish MF et al. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297:1689-92 (Pubitemid 35000781)
26. Li L, Yao Z (2004) Mast cell and immune inhibitory receptors. Cell Mol Immunol 1:408-15
27. Lu LF, Lind EF, Gondek DC et al. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997-1002 (Pubitemid 44330250)
28. Maeda M, Carpenito C, Russell RC et al. (2005) Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J Immunol 175:4426-32 (Pubitemid 41361978)
29. Maiza H, Leca G, Mansur IG et al. (1993) A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J Exp Med 178:1121-6 (Pubitemid 23260453)
30. Malaviya R, Twesten NJ, Ross EA et al. (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490-6 (Pubitemid 26065860)
31. Metz CN, Thomas P, Davitz MA (1992) Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions. Am J Pathol 140: 1275-81
32. Nikolova M, Lelievre JD, Carriere M et al. (2009) Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets. Blood 113:4556-65
33. Nikolova M, Marie-Cardine A, Boumsell L et al. (2002) BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int Immunol 14:445-51 (Pubitemid 34525065)
34. Nikolova MH, Muhtarova MN, Taskov HB et al. (2005) The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients. Cell Immunol 237:96-105 (Pubitemid 43117205)
35. Rey J, Giustiniani J, Mallet F et al. (2006) The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function. Eur J Immunol 36:2359-66 (Pubitemid 44420592)
36. Romero X, Benitez D, March S et al. (2004) Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens 64:132-44 (Pubitemid 38969577)
37. Rumsaeng V, Cruikshank WW, Foster B et al. (1997) Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 159:2904-10 (Pubitemid 127681313)
38. Schofield JN, Rademacher TW (2000) Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene. Biochim Biophys Acta 1494:189-94
39. Secor VH, Secor WE, Gutekunst CA et al. (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813-22
40. Skokos D, Botros HG, Demeure C et al. (2003) Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol 170:3037-45 (Pubitemid 36302178)
41. Skokos D, Le Panse S, Villa I et al. (2001) Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166:868-76 (Pubitemid 32060240)
42. Stelekati E, Bahri R, D'Orlando O et al. (2009) Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 31:665-76
43. Tsujimura K, Obata Y, Matsudaira Y et al. (2006) Characterization of murine CD160+ CD8+ T lymphocytes. Immunol Lett 106:48-56 (Pubitemid 44093052)
44. Valadi H, Ekstrom K, Bossios A et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-9 (Pubitemid 47214727)
45. Wolters PJ, Mallen-St Clair J, Lewis CC et al. (2005) Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy 35:82-8 (Pubitemid 40188275)
46. Yamada N, Matsushima H, Tagaya Y et al. (2003) Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J Invest Dermatol 121:1425-32 (Pubitemid 38005496)
47. Yokoi H, Choi OH, Hubbard W et al. (2008) Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol 121:499-505
48. Yokoi H, Myers A, Matsumoto K et al. (2006) Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 61:769-76 (Pubitemid 43801413)